These are the first clinical study results for the drug in a large population of patients with darker skin tones ...

That is why global cooperation is so crucial to rare disease research. National, international and community partnerships and ...

The US Food and Drug Administration (FDA) has approved Nuvation Bio’s Ibtrozi (taletrectinib) to treat adults with a rare and ...

Alongside the data in PsA, UCB will present at EULAR new results demonstrating that Bimzelx delivered sustained clinical ...

Today, by contrast, the marketers I study complain of being swamped by data and confused by information overload. And when I ...

Galderma has shared positive two-year data for its monoclonal antibody Nemluvio (nemolizumab) in moderate-to-severe atopic ...

NewAmsterdam Pharma has shared promising Alzheimer’s disease (AD) biomarker data from a late-stage study of its ...

As the concept of sustainability gains traction in healthcare, it is beginning to influence how value is assessed and ...

Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the European Commission (EC) to treat adults with ...

Results from the study’s open-label period, presented at this year’s European Renal Association Congress, showed that ...

By combining different treatment options – especially those involving immuno-oncology (IO) – researchers aim to develop ...

Merck & Co – known as MSD outside the US and Canada – has announced that its respiratory syncytial virus (RSV) preventive ...